BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 36583755)

  • 1. m6A-related bioinformatics analysis and functional characterization reveals that METTL3-mediated NPC1L1 mRNA hypermethylation facilitates progression of atherosclerosis via inactivation of the MAPK pathway.
    Zhang G; Li X; Huang X
    Inflamm Res; 2023 Mar; 72(3):429-442. PubMed ID: 36583755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL3 (Methyltransferase Like 3)-Dependent N6-Methyladenosine Modification on
    Li Q; Yu L; Gao A; Ren R; Zhang J; Cao L; Wang X; Liu Y; Qi W; Cai L; Li W; Wang W; Guo X; Su G; Yu X; Zhang J; Xi B; Zhang Y; Zhang M; Zhang C
    Arterioscler Thromb Vasc Biol; 2023 May; 43(5):755-773. PubMed ID: 36951060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N6-Methyladenosine Methyltransferase METTL3 Promotes Angiogenesis and Atherosclerosis by Upregulating the JAK2/STAT3 Pathway via m6A Reader IGF2BP1.
    Dong G; Yu J; Shan G; Su L; Yu N; Yang S
    Front Cell Dev Biol; 2021; 9():731810. PubMed ID: 34950654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methyltransferase-like 14 silencing relieves the development of atherosclerosis via m
    Liu Y; Luo G; Tang Q; Song Y; Liu D; Wang H; Ma J
    Bioengineered; 2022 May; 13(5):11832-11843. PubMed ID: 35543357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration of N6-Methyladenosine Profiles of mRNAs and the Function of METTL3 in Atherosclerosis.
    Zhou Y; Jiang R; Jiang Y; Fu Y; Manafhan Y; Zhu J; Jia E
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chinese Ecliptae herba (Eclipta prostrata (L.) L.) extract and its component wedelolactone enhances osteoblastogenesis of bone marrow mesenchymal stem cells via targeting METTL3-mediated m6A RNA methylation.
    Tian S; Li YL; Wang J; Dong RC; Wei J; Ma Y; Liu YQ
    J Ethnopharmacol; 2023 Aug; 312():116433. PubMed ID: 37004744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role of N6-methyladenosine modification of LncRNAs in contributing to the pathogenesis of chronic glomerulonephritis.
    Liu T; Zhuang XX; Qin XJ; Wei LB; Gao JR
    Inflamm Res; 2023 Mar; 72(3):623-638. PubMed ID: 36700958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The m6A methylation profiles of immune cells in type 1 diabetes mellitus.
    Wang Y; Xu L; Luo S; Sun X; Li J; Pang H; Zhou J; Zhou Y; Shi X; Li X; Huang G; Xie Z; Zhou Z
    Front Immunol; 2022; 13():1030728. PubMed ID: 36457997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin attenuates multiple myeloma cell proliferation and encourages apoptosis by suppressing METTL3-mediated m6A methylation of THRAP3, RBM25, and USP4.
    Chen CJ; Huang JY; Huang JQ; Deng JY; Shangguan XH; Chen AZ; Chen LT; Wu WH
    Cell Cycle; 2023 Apr; 22(8):986-1004. PubMed ID: 36762777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer.
    Xu Y; Song M; Hong Z; Chen W; Zhang Q; Zhou J; Yang C; He Z; Yu J; Peng X; Zhu Q; Li S; Ji K; Liu M; Zuo Q
    J Exp Clin Cancer Res; 2023 Jan; 42(1):10. PubMed ID: 36609396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. METTL3-Mediated lncRNA m
    Song Y; Pan Y; Wu M; Sun W; Luo L; Zhao Z; Liu J
    Stem Cell Rev Rep; 2021 Dec; 17(6):2276-2290. PubMed ID: 34505967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL3-dependent N
    Chien CS; Li JY; Chien Y; Wang ML; Yarmishyn AA; Tsai PH; Juan CC; Nguyen P; Cheng HM; Huo TI; Chiou SH; Chien S
    Proc Natl Acad Sci U S A; 2021 Feb; 118(7):. PubMed ID: 33579825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of m6A modification in lipopolysaccharide-induced acute lung injury in mice.
    Xu C; Song C; Wang W; Liu B; Li G; Fu T; Hao B; Li N; Geng Q
    Mol Med; 2024 Jan; 30(1):14. PubMed ID: 38254010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.
    Xie W; Ma LL; Xu YQ; Wang BH; Li SM
    Biochem Biophys Res Commun; 2019 Oct; 518(1):120-126. PubMed ID: 31405565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quercetin ameliorated insulin resistance via regulating METTL3-mediated N6-methyladenosine modification of PRKD2 mRNA in skeletal muscle and C2C12 myocyte cell line.
    Jiao Y; Williams A; Wei N
    Nutr Metab Cardiovasc Dis; 2022 Nov; 32(11):2655-2668. PubMed ID: 36058761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. METTL3-Mediated N6-Methyladenosine Methylation Modifies Foxp3 mRNA Levels and Affects the Treg Cells Proportion in Peripheral Blood of Patients with Asthma.
    Fan L; Wu J; Wang H; Chen Q; He X; Wang Q; Yang Z
    Ann Clin Lab Sci; 2022 Nov; 52(6):884-894. PubMed ID: 36564065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA PVT1 knockdown alleviated ox-LDL-induced vascular endothelial cell injury and atherosclerosis by miR-153-3p/GRB2 axis via ERK/p38 pathway.
    Guo J; Li J; Zhang J; Guo X; Liu H; Li P; Zhang Y; Lin C; Fan Z
    Nutr Metab Cardiovasc Dis; 2021 Nov; 31(12):3508-3521. PubMed ID: 34627697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Transcriptomic Profiling of m6A Modification in Age-Related Hearing Loss.
    Feng M; Zhou X; Hu Y; Zhang J; Yang T; Chen Z; Yuan W
    Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.